Cardiomyopathy Arrhythmia Risk Evaluation

CompletedOBSERVATIONAL
Enrollment

164

Participants

Timeline

Start Date

July 31, 2015

Primary Completion Date

June 30, 2019

Study Completion Date

June 30, 2019

Conditions
Cardiomyopathy
Trial Locations (1)

M5G 2C4

University Health Network, Toronto

All Listed Sponsors
lead

University Health Network, Toronto

OTHER

NCT02560844 - Cardiomyopathy Arrhythmia Risk Evaluation | Biotech Hunter | Biotech Hunter